Cargando…
Cannabis Extract CT-921 Has a High Efficacy–Adverse Effect Profile in a Neuropathic Pain Model
BACKGROUND: Legalization of cannabis encourages the development of specific cultivars to treat disease such as neuropathic pain. Because of the large number of cultivars, it is necessary to prioritize extracts before proceeding to clinical trials. PURPOSE: To compare extracts of two unique cannabis...
Autores principales: | Rouhollahi, Elham, MacLeod, Bernard A, Barr, Alasdair M, Puil, Ernest |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443010/ https://www.ncbi.nlm.nih.gov/pubmed/32884239 http://dx.doi.org/10.2147/DDDT.S247584 |
Ejemplares similares
-
Isovaline Does Not Activate GABA(B) Receptor-Coupled Potassium Currents in GABA(B) Expressing AtT-20 Cells and Cultured Rat Hippocampal Neurons
por: Pitman, Kimberley A., et al.
Publicado: (2015) -
Quantitative proteomic dataset of whole protein in three melanoma samples of 92.1, 92.1-A and 92.1-B
por: Fei, Xifeng, et al.
Publicado: (2022) -
Cannabis-Based Medicines and Medical Cannabis for Chronic Neuropathic Pain
por: Petzke, Frank, et al.
Publicado: (2021) -
Safety of Medical Cannabis in Neuropathic Chronic Pain Management
por: Bennici, Alessandra, et al.
Publicado: (2021) -
921. Acute HAV Infection in an Inpatient Psychiatry Unit
por: Weston, Gregory, et al.
Publicado: (2021)